Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ C10orf4 Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA530979
Description
Recommended positive controls: HeLa, HeLa nucleus. Predicted reactivity: Human (99%), Mouse (90%), Rat (91%), Pig (93%), Rhesus Monkey (98%), Bovine (94%). Store product as a concentrated solution. Centrifuge briefly prior to opening the vial.
The protein encoded by this gene is a nuclear phosphoprotein of unknown function. The 5' UTR of this gene is part of a CpG island and contains a tandem CGG repeat region that normally consists of 8-14 repeats but can expand to over 200 repeats. The expanded allele becomes hypermethylated and is not transcribed; however, an expanded repeat region has not been associated with any disease phenotype. This gene is found within the rare FRA10A folate-sensitive fragile site.
Specifications
C10orf4 | |
Polyclonal | |
Unconjugated | |
FRA10AC1 | |
5730455O13Rik; AI448293; C10orf4; F26C11.1-like; FRA10A; Fra10ac1; FRA10AC1 homolog (human); fragile site 10q23.3; fragile site, folic acid type, rare, fra(10)(q23.3) or fra(10)(q24.2) candidate 1; PRO2972; Protein FRA10AC1; protein FRA10AC1 homolog; rare folic acid-type fragile site, FRA(10)(q23.3), candidate gene 1; RGD1309482 | |
Rabbit | |
Antigen affinity chromatography | |
RUO | |
118924 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Liquid |
Western Blot, Immunocytochemistry | |
0.42 mg/mL | |
0.1M tris glycine with 20% glycerol and 0.01% thimerosal; pH 7 | |
Q70Z53 | |
FRA10AC1 | |
Recombinant protein fragment corresponding to a region within amino acids 1 and 192 of Human C10orf4. | |
100 μL | |
Primary | |
Human | |
Antibody | |
IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction